Takeda to vote on $62bn Shire acquisition, looming debt a factor
Takeda Pharmaceutical will hold an investor vote next month on the $62bn acquisition of rare disease specialist, Shire.
Top Headlines
Global Industry News
-
3D printed brain helps characterize 11 lead compounds, neuropathological research
from Outsourcing-Pharma.com
-
Medicon Valley: How Denmark and Sweden are ‘bridging’ the biotech gap
from BioPharma-Reporter.com
-
First-in-man study appears to ‘awaken’ dormant hair follicles, says biotech
from BioPharma-Reporter.com
-
Science Exchange adds ADME/tox services to marketplace
from Outsourcing-Pharma.com
Hot Topics
-
Ardena: M&A growth fuels HQ expansion
Mergers and Acquisitions
-
Hovione expands production capacity of oral dosage forms
Globalisation
-
Public-private engage on climate change, same needs to happen for AMR, says DSM
Globalisation
-
Allergan moves away from $200m plant expansion in Texas
Lifecycle Management
